Trimethoprim-sulfamethoxazole or clindamycin for community-associated MRSA (CA-MRSA) skin infections.
J Am Board Fam Med. 2010 Nov-Dec;23(6):714-9
Authors: Frei CR, Miller ML, Lewis JS, Lawson KA, Hunter JM, Oramasionwu CU, Talbert RL
In the United States, community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) has emerged as the predominant cause of skin infections. Trimethoprim-sulfamethoxazole (TMP-SMX) and clindamycin are often used as first-line treatment options, but clinical data are lacking.
PMID: 21057066 [PubMed - indexed for MEDLINE]